1. Home
  2. ASRT vs ATOM Comparison

ASRT vs ATOM Comparison

Compare ASRT & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • ATOM
  • Stock Information
  • Founded
  • ASRT 1995
  • ATOM 2001
  • Country
  • ASRT United States
  • ATOM United States
  • Employees
  • ASRT N/A
  • ATOM N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • ATOM Semiconductors
  • Sector
  • ASRT Health Care
  • ATOM Technology
  • Exchange
  • ASRT Nasdaq
  • ATOM Nasdaq
  • Market Cap
  • ASRT 105.8M
  • ATOM 100.9M
  • IPO Year
  • ASRT 1997
  • ATOM 2016
  • Fundamental
  • Price
  • ASRT $0.81
  • ATOM $5.79
  • Analyst Decision
  • ASRT Strong Buy
  • ATOM Strong Buy
  • Analyst Count
  • ASRT 4
  • ATOM 1
  • Target Price
  • ASRT $3.19
  • ATOM $7.00
  • AVG Volume (30 Days)
  • ASRT 862.2K
  • ATOM 461.9K
  • Earning Date
  • ASRT 11-11-2024
  • ATOM 10-29-2024
  • Dividend Yield
  • ASRT N/A
  • ATOM N/A
  • EPS Growth
  • ASRT N/A
  • ATOM N/A
  • EPS
  • ASRT N/A
  • ATOM N/A
  • Revenue
  • ASRT $125,763,000.00
  • ATOM $662,000.00
  • Revenue This Year
  • ASRT N/A
  • ATOM N/A
  • Revenue Next Year
  • ASRT $4.68
  • ATOM $2,800.00
  • P/E Ratio
  • ASRT N/A
  • ATOM N/A
  • Revenue Growth
  • ASRT N/A
  • ATOM 13140.00
  • 52 Week Low
  • ASRT $0.73
  • ATOM $2.31
  • 52 Week High
  • ASRT $1.80
  • ATOM $9.19
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 30.77
  • ATOM 69.99
  • Support Level
  • ASRT $0.82
  • ATOM $4.30
  • Resistance Level
  • ASRT $1.07
  • ATOM $7.11
  • Average True Range (ATR)
  • ASRT 0.07
  • ATOM 0.61
  • MACD
  • ASRT -0.02
  • ATOM 0.14
  • Stochastic Oscillator
  • ASRT 8.29
  • ATOM 65.17

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About ATOM Atomera Incorporated

Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the most widely used transistor type in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, FinFET technology, logic and processors, and SRAM.

Share on Social Networks: